FDA approves long-acting testosterone drug amid controversy

FDA approves long-acting testosterone drug amid controversy

The Irish drugmaker said the FDA approved Aveed for men with low testosterone, a condition sometimes associated with fatigue, weight gain and low libido. Endo's injection is to be taken once every 10 weeks, versus weekly or biweekly dosing for

3
Like
Save

Comments

Write a comment

*